Joseph Saveri Selected to “America’s Top 100 Attorneys”
Joseph Saveri has been selected as one of “America’s Top 100 Attorneys” by America’s Top 100 LLC.
Joseph Saveri Law Firm Wins 5th ACQ5 Award
The Joseph Saveri Law Firm was named “Antitrust Litigation Law Firm of the Year” by ACQ5 in its 2016 Law Awards. This represents the fifth award the firm has received from ACQ (Acquisition Finance magazine), a leading corporate magazine news site. Previous awards to the firm and Joseph Saveri include:
Intel Employees in Folsom Receive Holiday Windfall
(Sacramento Bee) Employees at Intel’s campus in Folsom last week began receiving checks for thousands of dollars as part of a $415 million settlement of a lawsuit involving some of the tech industry’s biggest players.
Experts Say Latest Reverse Payments Could Lead to High Court Action
(Bloomberg Bureau of National Affairs) In an opinion that could very well be a game-changer for drug companies involved in antitrust cases challenging the legality of patent litigation settlements, a federal judge Nov. 5 ruled that a 2013 U.S. Supreme Court holding doesn’t bar the door to testimony about the strength of the patent underlying a challenged settlement (King Drug Co. of […]
NEC Tokin to Plead Guilty to Criminal Price Fixing
On September 2, 2015, the Department of Justice filed a criminal information against NEC Tokin Corporation in the U.S. District Court of the Northern District of California in San Francisco, alleging its violation of Sherman Act Section 1 for fixing prices on electrolytic capacitors. NEC Tokin has agreed to plead guilty and pay a $13.8 million criminal fine for conspiring with […]
Joseph Saveri Selected by Best Lawyers as Antitrust Litigation “Lawyer of the Year” in San Francisco
(Best Lawyers) Joseph Saveri was recently selected by his peers as the Antitrust Litigation “Lawyer of the Year” in San Francisco, as featured in Best Lawyers 2015 – San Francisco.
California High Court Won’t Rehear Cipro Pay-For-Delay Ruling More
(Law360) The California Supreme Court declined Wednesday to revisit its May ruling reviving drug buyers’ claims that Bayer Corp. illegally paid generic manufacturers $400 million to delay launching copycat versions of blockbuster antibiotic Cipro, clearing the way for buyers to challenge the so-called pay-for-delay pharmaceutical patent settlements under state antitrust law.
Joseph Saveri Participates in California Lawyer Antitrust Roundtable
(California Lawyer) California Lawyer met with Daniel Asimow of Arnold & Porter; Maxwell Blecher of Blecher Collins Pepperman & Joye; Peter K. Huston of Sidley Austin; and Joseph Saveri of the Joseph Saveri Law Firm. The roundtable was reported by Cherree Peterson of Barkley Court Reporters.
Joseph Saveri Law Firm Brings RICO Case on Behalf of Paskenta Band of Nomlaki Indians
(PRNewswire-USNewswire) The Paskenta Band of Nomlaki Indians today filed a lawsuit in federal court charging its former treasurer and three former senior officials with defrauding the Tribe of tens of millions of dollars that otherwise would have been used to improve the lives of Tribal members. The complaint alleges that these four individuals used vote-rigging, bribery, and extortion […]
Cal Supreme Court Hears Oral Arguments in Cipro
The California Supreme Court today heard oral arguments In re Cipro Cases I & II. The firm represents a class of California consumers and insurers who brought antitrust claims against Bayer Corporation, Barr Laboratories, and other generic drug companies.